Enlivex Therapeutics Price Chart
Enlivex Therapeutics Volume Chart
Enlivex Therapeutics Market Segments
After Hours
+0.04(+3.92%)
| Open | $1.02 |
|---|---|
| Close | $1.06 |
| Low | $1.02 |
| Low Change | 0.00 (0.00%) |
| High | $1.06 |
| High Change | +0.04 (+3.92%) |
| Range | $0.04 |
| Volume | 1.125K |
| Dollar Volume | $1.19K |
Regular Trading Hours
+0.00(+0.00%)
| Open | $1.05 |
|---|---|
| Close | $1.05 |
| Low | $1.03 |
| Low Change | -0.02 (-1.90%) |
| High | $1.10 |
| High Change | +0.05 (+4.64%) |
| Range | $0.07 |
| Volume | 98.317K |
| Dollar Volume | $103.23K |
Premarket
*No Trades in Segment
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
-0.04(-3.57%)
| Open | $1.12 |
|---|---|
| Close | $1.08 |
| Low | $1.06 |
| Low Change | -0.06 (-5.36%) |
| High | $1.14 |
| High Change | +0.02 (+1.56%) |
| Range | $0.08 |
| Volume | 215.992K |
| Dollar Volume | $233.27K |
Premarket Yesterday
+0.03(+3.06%)
| Open | $1.11 |
|---|---|
| Close | $1.14 |
| Low | $1.11 |
| Low Change | 0.00 (0.00%) |
| High | $1.14 |
| High Change | +0.03 (+3.06%) |
| Range | $0.03 |
| Volume | 691 |
| Dollar Volume | $790.50 |
Enlivex Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $1.14 |
|---|---|
| 10 Day Moving Average (SMA10) | $1.15 |
| 20 Day Moving Average (SMA20) | $1.12 |
| 50 Day Moving Average (SMA50) | $1.05 |
| 100 Day Moving Average (SMA100) | $1.01 |
| 200 Day Moving Average (SMA200) | $1.08 |
Enlivex Therapeutics Statistics
| Average Volume (30 Days) | 287.42K |
|---|---|
| P/E Ratio (Current) | -22.40 |
| EPS (Current) | -$0.05 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$7.19M |
| Cash Ratio | 1.30 |
| Current Ratio | 1.85 |
| Quick Ratio | 1.85 |
| Debt to Equity | 0.00 |
| Enterprise Value | $260.19M |
| EV to EBITDA | -25.57 |
| EV to Sales | — |
| Price to Book | 7.49 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.29% |
| Return on Equity | -0.33% |
Enlivex Therapeutics Stock Splits
There have been 2 stock splits for Enlivex Therapeutics (ENLV). The last reverse stock split occured on March 6, 2019 and reduced the outstanding shares at a ratio of 8:1.
| Date | Type | Ratio |
|---|---|---|
| Mar 6, 2019 | Reverse | 8:1 |
| Sep 25, 2017 | Reverse | 5:1 |
Enlivex Therapeutics Dividends
There have been no dividends for Enlivex Therapeutics (ENLV).